ATLASCellectar Biosciences (CLRB) earnings date: Nov 12, 2026
Cellectar Biosciences (CLRB) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026, before the open. Analysts expect EPS of -$0.46.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CLRB
| Last price | $1.23 (+1.7%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.7% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Cellectar Biosciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Cellectar Biosciences reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Cellectar Biosciences. You can switch it off at any time.
Alert me before CLRB reportsFree to start. Creating an account takes under a minute.
CLRB earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.46 |
| Last report | Aug 13, 2026 · Miss |
| Beat rate (last 5 reports) | 4 of 5 (80%) |
| Average EPS surprise | +24.6% |
| Average move around a report | ±2.7% (last 5) |
| Sector | Healthcare · Biotechnology |
Cellectar Biosciences earnings history: last 5 reports
Cellectar Biosciences last reported on Aug 13, 2026: EPS of -$0.57 against an estimate of -$0.52 (-9.6% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.52 | -$0.57 | -9.6% | Miss | 0.0% |
| May 14, 2026 | -$1.88 | -$1.33 | +29.3% | Beat | +5.1% |
| May 6, 2026 | $2.55 | $2.72 | +6.7% | Beat | +3.8% |
| Mar 13, 2026 | $0.05 | $0.07 | +40.0% | Beat | +1.2% |
| Mar 4, 2026 | -$1.23 | -$0.53 | +56.9% | Beat | +3.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CLRB
See the fair value, the probability range and the earnings history of Cellectar Biosciences on its ATLAS page.
Cellectar Biosciences (CLRB) stock analysisPlans from €3.99 a month.
Cellectar Biosciences earnings: frequently asked questions
When does Cellectar Biosciences (CLRB) report earnings?
Cellectar Biosciences is scheduled to report on Thursday, November 12, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CLRB?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.46 per share (USD). Estimates can change before the report.
How often does CLRB beat earnings estimates?
Of its last 5 reports with a recorded result, Cellectar Biosciences beat the EPS estimate 4 times; the average surprise was +24.6%. Past results do not predict the next one.
How much does CLRB move around earnings?
Over its last 5 reports the stock moved an average of 2.7% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did Cellectar Biosciences beat earnings estimates last quarter?
Cellectar Biosciences last reported on Aug 13, 2026: EPS of -$0.57 against an estimate of -$0.52 (-9.6% surprise), a miss.
How much does CLRB usually move in a day?
On a normal trading day the ATLAS model puts CLRB’s one-day range at about ±4.7%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer